Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page displays a new site notice about a lapse in government funding and adds a revision tag for v3.4.1, replacing v3.4.0; these are general site maintenance updates and do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:17:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, a new 'Last Update Submitted that Met QC Criteria' label, and a 'No FEAR Act Data' disclosure, along with a revision of the page version from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:00:08.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page reflects a new revision (v3.3.4) replacing the previous v3.3.3 revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:57:34.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Expanded the study location listing to include numerous new sites across the US, Argentina, Australia, Europe, Asia, and other regions, while removing several previously listed locations.
    Difference
    3%
    Check dated 2025-12-23T09:18:45.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is a routine update and does not affect study content, eligibility, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:20:58.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The study documents section shows a revision update from v3.2.0 to v3.3.1. This appears to be a minor documentation update with no changes to the study design, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2025-11-24T13:11:59.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.